<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    VIVUS, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About VIVUS, Inc.

    With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We are a focused organization with the expertise and insights to advance innovative new therapies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      John Amos
    • FOUNDED
      1991
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Sienna Biopharmaceuticals, Inc.

    Sienna Biopharmaceuticals, Inc.

    Sienna Biopharmaceuticals, Inc. is a clinical–stage biopharmaceutical company fo...

    Sienna Biopharmaceuticals, Inc. is a clinicalâ€...

    Filing Type:    PU
    Oxford Immunotec Global PLC

    Oxford Immunotec Global PLC

    We are a global, high-growth diagnostics company committed to improving patient ca...

    We are a global, high-growth diagnostics compan...

    Filing Type:    PU
    Ra Pharmaceuticals, Inc.

    Ra Pharmaceuticals, Inc.

    Ra PharmaÂŽ is a clinical-stage biopharmaceutical company using a proprietary pept...

    Ra PharmaÂŽ is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Spark Therapeutics, Inc.

    Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitabi...

    Spark Therapeutics, a fully integrated company,...

    Filing Type:    PU
    Melinta Therapeutics, Inc.

    Melinta Therapeutics, Inc.

    Melinta Therapeutics, Inc. is dedicated to saving lives threatened by the global p...

    Melinta Therapeutics, Inc. is dedicated to savi...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.